Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.
出版信息
Br J Clin Pharmacol. 1989 Aug;28(2):211P-247P. doi: 10.1111/j.1365-2125.1989.tb05422.x.
Abstract
摘要
相似文献
1
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.
Br J Clin Pharmacol. 1989 Aug;28(2):211P-247P. doi: 10.1111/j.1365-2125.1989.tb05422.x.
2
Proceedings of the British Pharmacological Society. Bristol, 5-7th April. Abstracts.
Br J Pharmacol. 1989 Jul;97 Suppl(Suppl):369P-605P.
3
Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.
Br J Clin Pharmacol. 1990 Aug;30(2):303P-43P. doi: 10.1111/j.1365-2125.1990.tb03781.x.
4
Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.
Br J Clin Pharmacol. 1993 Aug;36(2):139P-182P. doi: 10.1111/j.1365-2125.1993.tb04214.x.
5
Proceedings of the British Pharmacological Society Meeting. University of Bristol, 23-25 July 1997. Abstracts.
Br J Pharmacol. 1997 Oct;122 Suppl(Suppl):1P-191P.
6
Proceedings of the British Pharmacological Society Meeting, joint meeting with the Portuguese Society of Pharmacology. 8-9 April 1999. Abstracts.
Br J Pharmacol. 1999 Jun;127 Suppl(Suppl):1P-143P.
7
Proceedings of the British Pharmacological Society Meeting, Joint Meeting with British Opioid Colloquium. 14-16 April 1993. Abstracts.
Br J Pharmacol. 1993 Jul;109 Suppl(Suppl):1P-142P.
8
Proceedings of the British Pharmacological Society meeting. Manchester, 13-15 April 1994. Abstracts.
Br J Pharmacol. 1994 Jul;112 Suppl(Suppl):442P-661P.
9
Proceedings of the British Pharmacological Society Meeting. Tyne, 8-10 April 1992. Abstracts.
Br J Pharmacol. 1992 Jul;106 Suppl(Suppl):1P-147P.
10
Proceedings of the British Pharmacological Society. 11th-13th April, 1984. Abstracts.
Br J Pharmacol. 1984 Jun;82 Suppl(Suppl):195P-348P.
本文引用的文献
1
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
J Med Genet. 1980 Apr;17(2):102-5. doi: 10.1136/jmg.17.2.102.
2
The inhibitory action of procaine, (+)-propranolol and (+/-)-propranolol on human sperm motility: antagonism by caffeine.
Br J Clin Pharmacol. 1981 Nov;12(5):751-3. doi: 10.1111/j.1365-2125.1981.tb01301.x.
3
Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status.
Clin Chem. 1981 Nov;27(11):1911-4.
4
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.
N Engl J Med. 1980 Jul 10;303(2):66-71. doi: 10.1056/NEJM198007103030202.
5
Prediction of creatinine clearance from serum creatinine in spinal cord injury patients.
Paraplegia. 1983 Feb;21(1):23-9. doi: 10.1038/sc.1983.4.
6
Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.
Blood. 1983 May;61(5):889-93.
7
Predisposition to phenytoin hepatotoxicity assessed in vitro.
N Engl J Med. 1981 Sep 24;305(13):722-7. doi: 10.1056/NEJM198109243051302.
8
Measurement of stroke volume with impedance cardiography.
Clin Physiol. 1982 Oct;2(5):409-17. doi: 10.1111/j.1475-097x.1982.tb00047.x.
9
The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
J Antimicrob Chemother. 1984 Feb;13(2):191-6. doi: 10.1093/jac/13.2.191.
Zotero 插件